poster

Computer-Assisted Trial Design (CATD) for PEG-IFN with Using PD Marker to Predict Efficacy

Thursday 16 October, 2025

Computer-assisted trial design (CATD) approach in drug development has recently been increasing to assure qualitative and efficient conduct of clinical…

Read more

Population pharmacokinetics of long-term methotrexate in children with lymphoblastic leukemia

Thursday 16 October, 2025

A high dose Methotrexate (HD MTX) protocol was used for long-term treatment of 37 children, 20 males and 17 females…

Read more

Phenytoin covariate models for Michaelis-Menten pharmacokinetics in adult epileptic patients

Thursday 16 October, 2025

Phenytoin plasma concentration minima at steady state (Cmin) were monitored in 230 adult outpatients with epilepsy. The drug is metabolized…

Read more

Vancomycin population pharmacokinetic analysis in patients with hematological malignancies

Thursday 16 October, 2025

PDF of poster Introduction: The population approach and pharmacodynamic criteria have become available as tools in individualized antimicrobial therapy, leading…

Read more

Handling Concentrations Below Quantification Limit in Population

Thursday 16 October, 2025

Three practical strategies for handling concentrations below the quantification limit (BQL) in the context of the estimation of population parameters…

Read more

Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis

Thursday 16 October, 2025

Objectives: To develop a population pharmacokinetic (PK) and pharmacodynamic model of etanercept in patients with rheumatoid arthritis (RA), using the…

Read more

Validation Of An Amikacin Population Pharmacokinetics Model To Be Used In Intensive Care Unit

Thursday 16 October, 2025

Introduction: Amikacin (AMIK) is one of the most useful aminoglycoside in the treatment of severe G-negative infections. Intensive care unit’s…

Read more

Cefepime Monitoring in ICU Patients Using a Population Pharmacokinetic Approach

Thursday 16 October, 2025

Introduction: Cefepime is used in the treatment of severe infections caused by Gram-negative bacilli. Pharmacokinetic modifications observed in ICU patients…

Read more

The Use Of Physiologically Based Pharmacokinetic (PBPK) Model In Drug Development

Thursday 16 October, 2025

In PBPK models, the kinetics of a drug is related to physiological parameters (such as blood flow and tissue size)…

Read more

Pharmacokinetic Mixed Effects Modelling of S16257 After Oral Administration in the Beagle Dog; Combined Analysis

Thursday 16 October, 2025

The objectives of the study were to build a population pharmacokinetic model for S 16257 after oral administration in dogs…

Read more